BridgeMD
New treatment option for Selective Mutism
Official title VR Homework Exercises for Selective Mutism Treatment
ClinicalTrials.gov ID: NCT06882629
What this study is testing
- What it's testing
- Selective mustism (SM) is an anxiety disorder that manifests in childhood. Children with Children with SM do not speak in certain social situations where this is expected of them.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 13
You may be able to join if
- The child meets the DSM-5 criteria for SM (as a primary classification).
- The child is attending primary school.
- Referred to an academic center for Child and Adolescent Psychiatry (Levvel) for diagnosis and treatment of SM
- Psychiatric comorbidity is permitted, given that SM is the primary treatment target.
- Medication use is permitted, if stable for at least 4 weeks prior to the start of treatment.
You likely can't join if
- No participating parents.
- Parents do not have sufficient mastery of the Dutch language.
- Parents or child have an estimated IQ below 75.
- The child needs inpatient treatment.
- Children with a (medical) condition that is a contraindication for using a VR headset (epilepsy, claustrophobia, facial condition, sensitive...
- Parents receiving parental guidance which is not part of the standard treatment program.
See the full eligibility criteria
- The child meets the DSM-5 criteria for SM (as a primary classification).
- The child is attending primary school.
- Referred to an academic center for Child and Adolescent Psychiatry (Levvel) for diagnosis and treatment of SM
- Psychiatric comorbidity is permitted, given that SM is the primary treatment target.
- Medication use is permitted, if stable for at least 4 weeks prior to the start of treatment.
- No participating parents.
- Parents do not have sufficient mastery of the Dutch language.
- Parents or child have an estimated IQ below 75.
- The child needs inpatient treatment.
- Children with a (medical) condition that is a contraindication for using a VR headset (epilepsy, claustrophobia, facial condition, sensitive vestibular system, panic attacks)
- Parents receiving parental guidance which is not part of the standard treatment program.
- Children that have received protocolled behavior therapy for SM in the past 12 months.
The study team makes the final eligibility decision.
Where it's taking place
- Amsterdam, North Holland, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 13 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amsterdam, North Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.